The use of third-party service providers, so-called vendors, in the context of clinical trials of medicinal products for human use. TEST BioLaw Journal - Rivista di BioDiritto, [S. l.], n. 3, p. 329–350, 2024. DOI: 10.15168/2284-4503-3203. Disponível em: https://teseo-ojs35-test.archicoop.it/biolaw/article/view/3203. Acesso em: 7 jul. 2026.